EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Fibrosis appearing as disease progression on PET/CT following R-CHOP in newly diagnosed DLBCL

Erin A Dean, Julia Tran, June Herman, Nicole Foley, Xiaohui Zhao

Frontiers in Oncology · 26.06.2026 · 16

DOI: 10.3389/fonc.2026.1845484 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 26.06.2026. Verfasst von Erin A Dean und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of Californ…. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B-cell lymphoma (DLBCL) is a frequently encountered aggressive lymphoma in clinical practice. The immunochemotherapy regimen consisting of rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone (R-CHOP) is a standard first-line therapy that results in complete remission in the majority of patients. Here, we summarize the case of a patient with newly diagnosed DLBCL who, after completing a full 6-cycle course of R-CHOP, exhibited increasing uptake in her original retroperitoneal mass on her end-of-therapy and 3-month post-therapy 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) scans. Evaluation with further imaging studies, tissue biopsies, and minimally invasive measurable residual disease tests ruled out primary refractory lymphoma. The FDG-avidity of the lesion was attributed to the presence of fibrosis, as it resolved on subsequent PET/CT scans without further therapeutic interventions. This case demonstrates how fibrosis may mimic disease progression on PET/CT after a cytotoxic regimen in DLBCL and should be considered in the differential diagnosis for patients with positive PET/CT scans to potentially spare them from receiving next-line therapy.

Schlagwörter

Stichwörter der Autor:innen

DLBCLR-CHOPcase reportctDNAfibrosis

Autor:innen und Institutionen

  • Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
  • Department of Radiological Sciences, University of California, Irvine, Irvine, CA, United States.
  • Malignant Hematology, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
  • Department of Pathology, University of California Irvine, Irvine, CA, United States.

Zitieren

APA

Dean, E. A., Tran, J., Herman, J., Foley, N., & Zhao, X. (2026). Case Report: Fibrosis appearing as disease progression on PET/CT following R-CHOP in newly diagnosed DLBCL. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1845484

Vancouver

Dean EA, Tran J, Herman J, Foley N, Zhao X. Case Report: Fibrosis appearing as disease progression on PET/CT following R-CHOP in newly diagnosed DLBCL. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1845484

BibTeX
@article{Dean2026,
  author = {Dean, Erin A and Tran, Julia and Herman, June and Foley, Nicole and Zhao, Xiaohui},
  title = {Case Report: Fibrosis appearing as disease progression on PET/CT following R-CHOP in newly diagnosed DLBCL},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1845484}
}
Kostenlos starten →